Dyspnea in patients with cardiovascular diseases: clinical, diagnostic and pathophysiologic aspects
https://doi.org/10.21886/2712-8156-2024-5-4-6-14
Abstract
Dyspnea is one of the most common symptoms in patients with various diseases. Dyspnea in stable ischemic heart disease (IHD), especially in a patient with prior myocardial infarction, is in most cases considered as a manifestation of congestive heart failure (CHF). And often practicing physicians do not think about the possibility of another genesis of dyspnea in their patients. This may lead to overdiagnosis of CHF. The review presents data on the occurrence, prognostic significance, classification features, as well as methods of dyspnea evaluation in therapeutic patients. The peculiarities of dyspnea genesis in patients with IHD, CHF, as well as in elderly patients are described. The absence of a universal and accessible method of dyspnea assessment complicates its differential diagnosis, especially in patients with a combination of pathology of respiratory and cardiovascular systems. Further research is needed to develop methods of complex assessment of dyspnea in patients with cardiovascular and other diseases in different age groups.
About the Authors
V. D. Yupatov
Saratov State Medical University named after V.I. Razumovsky
Russian Federation
Russian Federation
Vladimir D. Yupatov, postgraduate student of the Department of Hospital Therapy, Faculty of Medicine
Saratov
N. A. Karoli
Saratov State Medical University named after V.I. Razumovsky
Russian Federation
Russian Federation
Karoli Nina Anatolievna, MD, Professor, Professor of the Department of Hospital Therapy, Faculty of Medicine
Saratov
References
1. Burki NK. Treatment of dyspnoea. Eur Respir J. 2024;63(1):2301565. DOI: 10.1183/13993003.01565-2023
2. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435-452. DOI: 10.1164/rccm.201111-2042ST
3. Hudler A, Holguin F, Althoff M, Fuhlbrigge A, Sharma S. Pathophysiology and clinical evaluation of the patient with unexplained persistent dyspnea. Expert Rev Respir Med. 2022;16(5):511-518. DOI: 10.1080/17476348.2022.2030222
4. Müller A, Mraz T, Wouters EF, van Kuijk SM, Amaral AF, Breyer-Kohansal R, et al. Prevalence of dyspnea in general adult populations: A systematic review and meta-analysis. Respir Med. 2023;218:107379. DOI: 10.1016/j.rmed.2023.107379
5. Chuchalin A.G. Dyspnea: neurobiological and clinical aspects. Terapevticheskii arkhiv. 2022;94(3):367-371. (In Russ.) DOI: 10.26442/00403660.2022.03.201397
6. Gumus A, Cinarka H, Kayhan S, Durakoglugil ME, Cure E, Hazıroglu M, et al. An Evaluation of Chronic Dyspnea in a Chest Disease Clinic. J Pulm Respir Med. 2014;04(02):1000173. DOI: 10.4172/2161-105x.1000173
7. Pesola GR, Ahsan H. Dyspnea as an independent predictor of mortality. Clin Respir J. 2016;10(2):142-152. DOI: 10.1111/crj.12191
8. Yarmedova S.F., Yavelov I.S., Drapkina O.M. Causes of shortness of breath in patients with stable coronary heart disease. Cardiovascular Therapy and Prevention. 2022;21(9):3334. (In Russ.) DOI: 10.15829/1728-8800-2022-3334
9. Shtegman O.A., Petrova M.M., Virva P.V. Genesis of dyspnea in ambulatory patients with suspected to the chronic heart failure. Siberian Medical Review. 2013;4(82):63-66. (In Russ.) eLIBRARY ID: 20466699 EDN: RFWRVH
10. Vertkin A. L., Topolyansky A.V., Knorring G.Ju., Abdullaeva A.U. Dyspnea at the outpatient visit. RMJ. 2017;4:290-295. (In Russ.) eLIBRARY ID: 30743143 EDN: XHMKFE
11. Strutynskij A.V., Baranov A.P., Rojtberg G.E., Gaponenkov Y.P. Osnovy semiotiki zabolevanij vnutrennih organov. 11th ed. Moscow: Medpress, 2017. (In Russ.) ISBN: 978-5-00030-427-3
12. Chuchalin A.G., Abrosimov V.N., Avdeev S.N. Respiratory medicine: The Guideline. V. 1. 2nd ed. Moscow: Litterra, 2017. (In Russ.) ISBN: 978-5-4235-0262-1
13. Dvoretskiy L.I., Rezvan V.V. Platypnea: оne more type position shortness of breath. Terapevticheskii arkhiv. 2020;92(3):92-97. (In Russ.) DOI: 10.26442/00403660.2020.03.000436
14. Thibodeau JT, Turer AT, Gualano SK, Ayers CR, Velez-Martinez M, Mishkin JD, et al. Characterization of a novel symptom of advanced heart failure: bendopnea. JACC Heart Fail. 2014;2(1):24-31. DOI: 10.1016/j.jchf.2013.07.009
15. Larina V.N., Bart B.Y., Chukaeva I.I., Karpenko D.G., Zacharova M.I., Kulbachinskaya O.M. Bendopnea: Association With Echocardiographic Features and Clinical Outcomes in Elderly Patients With Chronic Heart Failure. Kardiologiia. 2018;58(12):36-44. (In Russ.) DOI: 10.18087/cardio.2018.12.10190
16. Serezhina E.K., Obrezan A.G. Efficiency of bending test and spectral tracking echocardiography in diagnosis of heart failure with preserved ejection fraction. Kardiologiya: novosti, mneniya, obuchenie [Cardiology: News, Opinions, Training]. 2022;10(1):22-28. (in Russ.) DOI: 10.33029/2309-1908-2022-10-1-22-28
17. Sunjaya AP, Homaira N, Corcoran K, Martin A, Berend N, Jenkins C. Assessment and diagnosis of chronic dyspnoea: a literature review. NPJ Prim Care Respir Med. 2022;32(1):10. DOI: 10.1038/s41533-022-00271-1
18. Huang W, Resch S, Oliveira RK, Cockrill BA, Systrom DM, Waxman AB. Invasive cardiopulmonary exercise testing in the evaluation of unexplained dyspnea: Insights from a multidisciplinary dyspnea center. Eur J Prev Cardiol. 2017;24(11):1190-1199. DOI: 10.1177/2047487317709605
19. Hegendörfer E, Degryse JM. Breathlessness in older adults: What we know and what we still need to know. J Am Geriatr Soc. 2023;71(7):2082-2095. DOI: 10.1111/jgs.18326
20. Schloesser K, Bergmann A, Eisenmann Y, Pauli B, Hellmich M, Oberste M, et al. Only I Know Now, of Course, How to Deal With it, or Better to Deal With it: A Mixed Methods Phase II Study of a Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness. J Pain Symptom Manage. 2022;63(5):758-768. DOI: 10.1016/j.jpainsymman.2021.11.003
21. Ovcharenko S.I., Troshina D.V., Sokolova P.S., Volel B.A. Psychosomatic functional disorders in pulmonary practice. PULMONOLOGIYA. 2023;33(3):386-392. (In Russ.) DOI: 10.18093/0869-0189-2023-33-3-386-392
22. Chenivesse C, Similowski T, Bautin N, Fournier C, Robin S, Wallaert B, et al. Severely impaired health-related quality of life in chronic hyperventilation patients: exploratory data. Respir Med. 2014;108(3):517-523. DOI: 10.1016/j.rmed.2013.10.024
23. Barker N, Everard ML. Getting to grips with 'dysfunctional breathing'. Paediatr Respir Rev. 2015;16(1):53-61. DOI: 10.1016/j.prrv.2014.10.001
24. Simon PM, Schwartzstein RM, Weiss JW, Fencl V, Teghtsoonian M, Weinberger SE. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis. 1990;142(5):1009-1014. DOI: 10.1164/ajrccm/142.5.1009
25. Trushenko N.V., Chikina S.Yu., Lukashenko E.P., Chuchalin A.G. Verbal descriptions of dyspnea in patients with chronic obstructive pulmonary disease and bronchial asthma. PULMONOLOGIYA. 2011;1(3):70-80. (In Russ.) DOI: 10.18093/0869-0189-2011-0-3-70-80
26. Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016;18(6):613-625. Erratum in: Eur J Heart Fail. 2017;19(3):438. DOI: 10.1002/ejhf.566
27. Zheng J, Heidenreich PA, Kohsaka S, Fearon WF, Sandhu AT. Variability in Coronary Artery Disease Testing for Patients With New-Onset Heart Failure. J Am Coll Cardiol. 2022;79(9):849-860. DOI: 10.1016/j.jacc.2021.11.061
28. Valk MJ, Mosterd A, Broekhuizen BD, Zuithoff NP, Landman MA, Hoes AW, et al. Overdiagnosis of heart failure in primary care: a cross-sectional study. Br J Gen Pract. 2016;66(649):e587-92. DOI: 10.3399/bjgp16X685705
29. Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415-3537. DOI: 10.1093/eurheartj/ehae177
30. Brieger D, Eagle KA, Goodman SG, Steg PG, Budaj A, White K, et al. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. Chest. 2004;126(2):461-469. DOI: 10.1378/chest.126.2.461
31. Juarez-Orozco LE, Saraste A, Capodanno D, Prescott E, Ballo H, Bax JJ, et al. Impact of a decreasing pre-test probability on the performance of diagnostic tests for coronary artery disease. Eur Heart J Cardiovasc Imaging. 2019;20(11):1198-1207. DOI: 10.1093/ehjci/jez054
32. Douglas PS, Nanna MG, Kelsey MD, Yow E, Mark DB, Patel MR, et al. Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial. JAMA Cardiol. 2023;8(10):904-914. DOI: 10.1001/jamacardio.2023.2595
33. Schoenenberger AW, Felber S, Gujer S, Moser A, Jamshidi P, Stuck AE, et al. Invasive findings in patients with angina equivalent symptoms but no coronary artery disease; results from the heart quest cohort study. Int J Cardiol. 2013;167(1):168-173. DOI: 10.1016/j.ijcard.2011.12.053
34. Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol. 2012;59(7):655-662. DOI: 10.1016/j.jacc.2011.11.015
35. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. Erratum in: Eur Heart J. 2021;42(48):4901. DOI: 10.1093/eurheartj/ehab368
36. Farajidavar N, O'Gallagher K, Bean D, Nabeebaccus A, Zakeri R, Bromage D, et al. Diagnostic signature for heart failure with preserved ejection fraction (HFpEF): a machine learning approach using multi-modality electronic health record data. BMC Cardiovasc Disord. 2022;22(1):567. DOI: 10.1186/s12872-022-03005-w
37. Dubé BP, Agostoni P, Laveneziana P. Exertional dyspnoea in chronic heart failure: the role of the lung and respiratory mechanical factors. Eur Respir Rev. 2016;25(141):317-332. DOI: 10.1183/16000617.0048-2016
38. Scandalis L, Kitzman DW, Nicklas BJ, Lyles M, Brubaker P, Nelson MB, et al. Skeletal Muscle Mitochondrial Respiration and Exercise Intolerance in Patients With Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2023;8(6):575-584. DOI: 10.1001/jamacardio.2023.0957
39. Selvaraj S, Myhre PL, Vaduganathan M, Claggett BL, Matsushita K, Kitzman DW, et al. Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community. JACC Heart Fail. 2020;8(8):640-653. DOI: 10.1016/j.jchf.2020.03.013
40. van Riet EE, Hoes AW, Limburg A, Landman MA, van der Hoeven H, Rutten FH. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur J Heart Fail. 2014;16(7):772-777. DOI: 10.1002/ejhf.110
41. Smeets M, Vaes B, Aertgeerts B, Raat W, Penders J, Vercammen J, et al. Impact of an extended audit on identifying heart failure patients in general practice: baseline results of the OSCAR-HF pilot study. ESC Heart Fail. 2020;7(6):3950-3961. DOI: 10.1002/ehf2.12990
42. Medovchshikov V, Yeshniyazov N, Khasanova E, Kobalava Z. Similar Incidence of over and Underdiagnosis of Heart Failure in Hospitalized Patients with Type 2 Diabetes Mellitus. European Heart Journal. 2021;42(Supplement_1):ehab724.1005. DOI: 10.1093/eurheartj/ehab724.1005
43. Verdú-Rotellar JM, Frigola-Capell E, Alvarez-Pérez R, da Silva D, Enjuanes C, Domingo M, et al. Validation of heart failure diagnosis registered in primary care records in two primary care centres in Barcelona (Spain) and factors related. A cross-sectional study. Eur J Gen Pract. 2017;23(1):107-113. DOI: 10.1080/13814788.2017.1305104
44. Mahendra M, S SK, Desai N, Bs J, Pa M. Evaluation for airway obstruction in adult patients with stable ischemic heart disease. Indian Heart J. 2018;70(2):266-271. DOI: 10.1016/j.ihj.2017.08.003
45. Franssen FM, Soriano JB, Roche N, Bloomfield PH, Brusselle G, Fabbri LM, et al. Lung Function Abnormalities in Smokers with Ischemic Heart Disease. Am J Respir Crit Care Med. 2016;194(5):568-576. DOI: 10.1164/rccm.201512-2480OC
46. Dobler CC, Glasziou PP. Overdiagnosis in respiratory medicine. Respirology. 2019;24(10):939-941. DOI: 10.1111/resp.13623
47. Yeh RW, Tamez H, Secemsky EA, Grantham JA, Sapontis J, Spertus JA, et al. Depression and Angina Among Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention: The OPEN-CTO Registry. JACC Cardiovasc Interv. 2019;12(7):651-658. DOI: 10.1016/j.jcin.2018.12.029
48. Angiolillo DJ, Cao D, Sartori S, Baber U, Dangas G, Zhang Z, et al. Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2023;16(20):2514-2524. DOI: 10.1016/j.jcin.2023.08.019
49. Karev E.A., Malev E.G., Verbilo S.L., Prokudina M.N. Shortness of Breath on Exertion: Diagnostic Possibilities of Stress Echocardiography. Kardiologiia. 2021;61(2):62-68. (In Russ.) DOI: 10.18087/cardio.2021.2.n1320
Review
For citations:
Yupatov V.D., Karoli N.A. Dyspnea in patients with cardiovascular diseases: clinical, diagnostic and pathophysiologic aspects. South Russian Journal of Therapeutic Practice. 2024;5(4):6-14. (In Russ.) https://doi.org/10.21886/2712-8156-2024-5-4-6-14
Views:
1227
Email this article 